Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07277738 · ClinicalTrials.gov registry record · NA
Precision Supplemental Imaging in Women With Dense Breasts
A NA study, sponsored by Washington University School of Medicine.
- Not yet
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT07277738 is a NA study that has not yet begun recruiting, run by Washington University School of Medicine. The registered enrollment target is 78 participants.
The verdict
NCT07277738, a NA study, has not yet begun recruiting, sponsored by Washington University School of Medicine.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Recent research has shown that, among women with extremely dense breasts and normal results on mammogram, magnetic resonance imaging (MRI) use has significantly reduced the occurrence of breast cancer that is diagnosed during the time between two regular screening mammograms (also known as interval cancers). The investigators have developed and validated an approach to use the whole mammogram image, develop a mammogram risk score (MRS), and calibrate this to the SEER breast cancer incidence rates for US women. This model (Prognosia Breast) generates an absolute 5-year risk of breast cancer and classifies approximately 5.7% of the population as high risk using the ASCO 3% cut point as used for endocrine therapy to reduce risk. Follow-up generates an incidence of 25.2 cases per 1,000 women per year.
Interventions
- DEVICE MRI
- DEVICE Prognosia Breast
- DEVICE Mammogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07277738
The ClinicalTrials.gov registry entry for NCT07277738 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MRI is the first listed.
NCT07277738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07277738 about?
NCT07277738 is a clinical study titled "Precision Supplemental Imaging in Women With Dense Breasts". Recent research has shown that, among women with extremely dense breasts and normal results on mammogram, magnetic resonance imaging (MRI) use has significantly reduced the occurrence of breast cancer that is diagnosed during the time between two regular screening mammograms (also known as interval ...
What is the current status of trial NCT07277738?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2026-06-30. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07277738?
The interventions under investigation include: MRI (DEVICE), Prognosia Breast (DEVICE), Mammogram (DEVICE).
Who is sponsoring clinical trial NCT07277738?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.